SYNGENE INTERNATIONAL
Back to Balance Sheet
|
SYNGENE INTERNATIONAL Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹643 Cr | ₹709 Cr | ₹955 Cr | ₹972 Cr | ₹840 Cr |
What is the latest Total Non-Current Liabilities ratio of SYNGENE INTERNATIONAL ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹643 Cr |
| Mar2024 | ₹709 Cr |
| Mar2023 | ₹955 Cr |
| Mar2022 | ₹972 Cr |
| Mar2021 | ₹840 Cr |
How is Total Non-Current Liabilities of SYNGENE INTERNATIONAL Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹643 Cr | -9.24 | |
| Mar2024 | ₹709 Cr | -25.79 | |
| Mar2023 | ₹955 Cr | -1.70 | |
| Mar2022 | ₹972 Cr | 15.72 | |
| Mar2021 | ₹840 Cr | - | |
Compare Total Non-Current Liabilities of peers of SYNGENE INTERNATIONAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNGENE INTERNATIONAL | ₹17,643.0 Cr | -1.3% | 10% | -42.7% | Stock Analytics | |
| SAGILITY INDIA | ₹19,703.7 Cr | -0.4% | 15.6% | -4.4% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹6,135.3 Cr | -2.3% | 18.7% | -26.3% | Stock Analytics | |
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,767.2 Cr | 2% | 35% | -8.7% | Stock Analytics | |
| JUST DIAL | ₹4,559.2 Cr | -2.8% | 7.2% | -46.4% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹2,501.8 Cr | -0.2% | 40.1% | -48.7% | Stock Analytics | |
SYNGENE INTERNATIONAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNGENE INTERNATIONAL | -1.3% |
10% |
-42.7% |
| SENSEX | -1.6% |
3.7% |
-2.7% |
You may also like the below Video Courses